全球液體止血劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計液體止血劑市場規模將從 2025 年的 8.3 億美元成長到 2034 年的 13.8 億美元，2026 年至 2034 年的複合年成長率為 5.86%。

由於全球外科手術和創傷病例數量的不斷增加，液體止血劑市場正穩步成長。外科醫師在複雜手術中依賴液體止血劑快速控制出血。需要手術介入的心血管和整形外科疾病的日益增多，也推動了醫院和手術中心對該產品的需求。

關鍵促進因素包括生物相容性材料的技術進步、產品療效的提升以及發展中地區醫療基礎設施的擴建。微創手術和門診手術的增加推動了先進止血劑的應用。積極的研發活動也促進了產品創新和市場競爭力的提升。

隨著醫療系統將病患安全和減少手術併發症列為優先事項，市場前景仍然強勁。對創傷護理和急診服務的投入增加將進一步支撐市場需求。隨著產品不斷創新以及全球手術數量的成長，液體止血劑市場預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球液體止血劑市場：依來源分類

• 市場分析、洞察與預測
• 源自牛
• 源自豬

第5章 全球液體止血劑市場：依應用分類

• 市場分析、洞察與預測
• 一般外科
• 心血管外科
• 整形外科手術
• 婦科手術
• 神經外科
• 重組手術
• 其他

第6章：全球液體止血劑市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 門診手術中心（ASC）
• 其他

第7章 全球液體止血劑市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • 3D Matrix Medical Technology
  • Aegis Lifesciences Private Limited
  • Baxter International Inc
  • CR Bard Inc.（Becton Dickinson Company）
  • Ethicon Inc.（Johnson & Johnson）
  • Ferrosan Medical Devices A/S
  • Integra LifeSciences Corporation
  • Medcura Inc
  • Pfizer Inc
  • Teleflex Incorporated

The Flowable Hemostats Market size is expected to reach USD 1.38 Billion in 2034 from USD 0.83 Billion (2025) growing at a CAGR of 5.86% during 2026-2034.

The flowable hemostats market is growing steadily due to increasing surgical procedures and rising trauma cases worldwide. Surgeons rely on flowable hemostats for rapid bleeding control in complex surgeries. The growing prevalence of cardiovascular diseases and orthopedic conditions requiring surgical intervention is boosting product demand across hospitals and surgical centers.

Drivers include technological advancements in biocompatible materials, improved product efficacy, and expanding healthcare infrastructure in developing regions. Minimally invasive surgeries and outpatient procedures are increasing the adoption of advanced hemostatic agents. Strong research and development activities are also contributing to product innovation and market competitiveness.

Future prospects remain strong as healthcare systems prioritize patient safety and reduced surgical complications. Increasing investments in trauma care and emergency response services will further support demand. With continuous product innovation and rising surgical volumes globally, the flowable hemostats market is expected to witness sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Origin

• Bovine
• Porcine

By Application

• General Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Gynecological Surgery
• Neurosurgery
• Reconstructive Surgery
• Other

By End-Use

• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCS)
• Other

COMPANIES PROFILED

• 3D Matrix Medical Technology, Aegis Lifesciences Private Limited, Baxter International Inc, CR Bard Inc Becton Dickinson Company, Ethicon Inc Johnson Johnson, Ferrosan Medical Devices AS, Integra LifeSciences Corporation, Medcura Inc, Pfizer Inc, Teleflex Incorporated
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FLOWABLE HEMOSTATS MARKET: BY ORIGIN 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Origin
• 4.2. Bovine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Porcine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FLOWABLE HEMOSTATS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Gynecological Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Reconstructive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FLOWABLE HEMOSTATS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers (ASCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FLOWABLE HEMOSTATS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Origin
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Origin
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Origin
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Origin
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Origin
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FLOWABLE HEMOSTATS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 3D Matrix Medical Technology
  • 9.2.2 Aegis Lifesciences Private Limited
  • 9.2.3 Baxter International Inc
  • 9.2.4 CR Bard Inc. (Becton Dickinson Company)
  • 9.2.5 Ethicon Inc. (Johnson & Johnson)
  • 9.2.6 Ferrosan Medical Devices A/S
  • 9.2.7 Integra LifeSciences Corporation
  • 9.2.8 Medcura Inc
  • 9.2.9 Pfizer Inc
  • 9.2.10 Teleflex Incorporated